Related references
Note: Only part of the references are listed.Effects of Evolocumab on the Postprandial Kinetics of Apo (Apolipoprotein) B100-and B48-Containing Lipoproteins in Subjects With Type 2 Diabetes
Marja-Riitta Taskinen et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2021)
Triglyceride-Rich Lipoprotein Remnants and Cardiovascular Disease
Edward K. Duran et al.
CLINICAL CHEMISTRY (2021)
Lipoprotein Lipase and Its Regulators: An Unfolding Story
Shuangcheng Alivia Wu et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2021)
Triglycerides and risk of atherosclerotic cardiovascular disease: An update
Michel Farnier et al.
ARCHIVES OF CARDIOVASCULAR DISEASES (2021)
ANGPTL3 Inhibition With Evinacumab Results in Faster Clearance of IDL and LDL apoB in Patients With Homozygous Familial Hypercholesterolemia-Brief Report
Laurens F. Reeskamp et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2021)
ANGPTL8 protein-truncating variant associated with lower serum triglycerides and risk of coronary disease
Pyry Helkkula et al.
PLOS GENETICS (2021)
Triglycerides and Residual Atherosclerotic Risk
Sergio Raposeiras-Roubin et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2021)
2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS)
Francois Mach et al.
EUROPEAN HEART JOURNAL (2020)
Rare dyslipidaemias, from phenotype to genotype to management: a European Atherosclerosis Society task force consensus statement
Robert A. Hegele et al.
LANCET DIABETES & ENDOCRINOLOGY (2020)
Real-world risk of cardiovascular outcomes associated with hypertriglyceridaemia among individuals with atherosclerotic cardiovascular disease and potential eligibility for emerging therapies
Patrick R. Lawler et al.
EUROPEAN HEART JOURNAL (2020)
Clinical review on triglycerides
Ulrich Laufs et al.
EUROPEAN HEART JOURNAL (2020)
Methodological issues regarding: A third of nonfasting plasma cholesterol is in remnant lipoproteins: Lipoprotein subclass profiling in 9293 individuals
Alan T. Remaley et al.
ATHEROSCLEROSIS (2020)
Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus statement from the European Atherosclerosis Society Consensus Panel
Jan Boren et al.
EUROPEAN HEART JOURNAL (2020)
Impact of proprotein convertase subtilisin/kexin type 9 inhibition with evolocumab on the postprandial responses of triglyceride-rich lipoproteins in type II diabetic subjects
Marja-Riitta Taskinen et al.
JOURNAL OF CLINICAL LIPIDOLOGY (2020)
Apolipoprotein B48 metabolism in chylomicrons and very low-density lipoproteins and its role in triglyceride transport in normo- and hypertriglyceridemic human subjects
E. Bjornson et al.
JOURNAL OF INTERNAL MEDICINE (2020)
Cholesterol Crystals are Associated with Carotid Plaque Vulnerability: An Optical Coherence Tomography Study
Xuan Shi et al.
JOURNAL OF STROKE & CEREBROVASCULAR DISEASES (2020)
Apolipoprotein C3 induces inflammation and organ damage by alternative inflammasome activation
Stephen Zewinger et al.
NATURE IMMUNOLOGY (2020)
Regulation of intestinal lipid metabolism: current concepts and relevance to disease
Chih-Wei Ko et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2020)
A New Equation for Calculation of Low-Density Lipoprotein Cholesterol in Patients With Normolipidemia and/or Hypertriglyceridemia
Maureen Sampson et al.
JAMA CARDIOLOGY (2020)
Remnants of the Triglyceride-Rich Lipoproteins, Diabetes, and Cardiovascular Disease
Alan Chait et al.
DIABETES (2020)
Triglycerides and remnant cholesterol associated with risk of aortic valve stenosis: Mendelian randomization in the Copenhagen General Population Study
Morten Kaltoft et al.
EUROPEAN HEART JOURNAL (2020)
LDL subclass lipidomics in atherogenic dyslipidemia: effect of statin therapy on bioactive lipids and dense LDL[S]
M. John Chapman et al.
JOURNAL OF LIPID RESEARCH (2020)
Causes and Consequences of Hypertriglyceridemia
Chris J. Packard et al.
FRONTIERS IN ENDOCRINOLOGY (2020)
Lomitapide-a Microsomal Triglyceride Transfer Protein Inhibitor for Homozygous Familial Hypercholesterolemia
Claudia Stefanutti
CURRENT ATHEROSCLEROSIS REPORTS (2020)
Remnant lipoproteins: are they equal to or more atherogenic than LDL?
Carlos A. Aguilar Salinas et al.
CURRENT OPINION IN LIPIDOLOGY (2020)
Regulation of lipoprotein lipase-mediated lipolysis of triglycerides
Debapriya Basu et al.
CURRENT OPINION IN LIPIDOLOGY (2020)
Cholesterol crystals and atherosclerosis
Yvonne Baumer et al.
EUROPEAN HEART JOURNAL (2020)
Non-HDL Cholesterol or apoB: Which to Prefer as a Target for the Prevention of Atherosclerotic Cardiovascular Disease?
Michel R. Langlois et al.
CURRENT CARDIOLOGY REPORTS (2020)
Genetics of Hypertriglyceridemia
Jacqueline S. Dron et al.
FRONTIERS IN ENDOCRINOLOGY (2020)
Angiopoietin-like protein 3 governs LDL-cholesterol levels through endothelial lipase-dependent VLDL clearance
Rene C. Adam et al.
JOURNAL OF LIPID RESEARCH (2020)
LDL-Cholesterol Reduction by ANGPTL3 Inhibition in Mice Is Dependent on Endothelial Lipase
Liya Wu et al.
CIRCULATION RESEARCH (2020)
Vupanorsen, an N-acetyl galactosamine-conjugated antisense drug to ANGPTL3 mRNA, lowers triglycerides and atherogenic lipoproteins in patients with diabetes, hepatic steatosis, and hypertriglyceridaemia
Daniel Gaudet et al.
EUROPEAN HEART JOURNAL (2020)
Evinacumab for Homozygous Familial Hypercholesterolemia
Frederick J. Raal et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Hypertriglyceridemia-Causes, Significance, and Approaches to Therapy
Leinys S. Santos-Baez et al.
FRONTIERS IN ENDOCRINOLOGY (2020)
Effect of High-Dose Omega-3 Fatty Acids vs Corn Oil on Major Adverse Cardiovascular Events in Patients at High Cardiovascular Risk The STRENGTH Randomized Clinical Trial
Stephen J. Nicholls et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
VLDL Cholesterol Accounts for One-Half of the Risk of Myocardial Infarction Associated With apoB-Containing Lipoproteins
Mie Balling et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2020)
Experimental Therapeutics for Challenging Clinical Care of a Patient with an Extremely Rare Homozygous APOC2 Mutation
Masako Ueda et al.
CASE REPORTS IN ENDOCRINOLOGY (2020)
Monocytes and Macrophages as Protagonists in Vascular Complications of Diabetes
Jenny E. Kanter et al.
FRONTIERS IN CARDIOVASCULAR MEDICINE (2020)
Remnant cholesterol and risk of ischemic stroke in 112,512 individuals from the general population
Anette Varbo et al.
ANNALS OF NEUROLOGY (2019)
Association of Triglyceride-Lowering LPL Variants and LDL-C-Lowering LDLR Variants With Risk of Coronary Heart Disease
Brian A. Ference et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2019)
Investigation of human apoB48 metabolism using a new, integrated non-steady-state model of apoB48 and apoB100 kinetics
E. Bjornson et al.
JOURNAL OF INTERNAL MEDICINE (2019)
Postprandial Hypertriglyceridaemia Revisited in the Era of Non-Fasting Lipid Profile Testing: A 2019 Expert Panel Statement, Main Text
Genovefa D. Kolovou et al.
CURRENT VASCULAR PHARMACOLOGY (2019)
Role of apolipoprotein C-III overproduction in diabetic dyslipidaemia
Martin Adiels et al.
DIABETES OBESITY & METABOLISM (2019)
Efficacy and safety of evolocumab in individuals with type 2 diabetes mellitus: primary results of the randomised controlled BANTING study
Robert S. Rosenson et al.
DIABETOLOGIA (2019)
ApoC-III ASO promotes tissue LPL activity in the absence of apoE-mediated TRL clearance[S]
Bastian Ramms et al.
JOURNAL OF LIPID RESEARCH (2019)
A third of nonfasting plasma cholesterol is in remnant lipoproteins: Lipoprotein subclass profiling in 9293 individuals
Mie Balling et al.
ATHEROSCLEROSIS (2019)
Glucose and GLP-2 (Glucagon-Like Peptide-2) Mobilize Intestinal Triglyceride by Distinct Mechanisms
Priska Stahel et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2019)
Inhibition of Angiopoietin-Like Protein 3 With a Monoclonal Antibody Reduces Triglycerides in Hypertriglyceridemia
Zahid Ahmad et al.
CIRCULATION (2019)
Omega-3 Fatty Acids for the Management of Hypertriglyceridemia: A Science Advisory From the American Heart Association
Ann C. Skulas-Ray et al.
CIRCULATION (2019)
Association Between Triglyceride Lowering and Reduction of Cardiovascular Risk Across Multiple Lipid-Lowering Therapeutic Classes A Systematic Review and Meta-Regression Analysis of Randomized Controlled Trials
Nicholas A. Marston et al.
CIRCULATION (2019)
Volanesorsen and Triglyceride Levels in Familial Chylomicronemia Syndrome
J. L. Witztum et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Altered HDL metabolism in metabolic disorders: insights into the therapeutic potential of HDL
Nicholas Hui et al.
CLINICAL SCIENCE (2019)
Lomitapide and Mipomersen-Inhibiting Microsomal Triglyceride Transfer Protein (MTP) and apoB100 Synthesis
Dirk J. Blom et al.
CURRENT ATHEROSCLEROSIS REPORTS (2019)
Effects of APOC3 Heterozygous Deficiency on Plasma Lipid and Lipoprotein Metabolism
Gissette Reyes-Soffer et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2019)
Low-Grade Inflammation in the Association between Mild-to-Moderate Hypertriglyceridemia and Risk of Acute Pancreatitis: A Study of More Than 115000 Individuals from the General Population
Signe E. J. Hansen et al.
CLINICAL CHEMISTRY (2019)
The Forgotten Lipids: Triglycerides, Remnant Cholesterol, and Atherosclerotic Cardiovascular Disease Risk
Pratik B. Sandesara et al.
ENDOCRINE REVIEWS (2019)
Mipomersen and its use in familial hypercholesterolemia
Johnathon Seth Parham et al.
EXPERT OPINION ON PHARMACOTHERAPY (2019)
2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol
Scott M. Grundy et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2019)
Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia
Deepak L. Bhatt et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Extracellular Lipids Accumulate in Human Carotid Arteries as Distinct Three-Dimensional Structures and Have Proinflammatory Properties
Satu Lehti et al.
AMERICAN JOURNAL OF PATHOLOGY (2018)
Macrophages Shed Excess Cholesterol in Unique Extracellular Structures Containing Cholesterol Microdomains
Xueting Jin et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2018)
Triglyceride-Rich Lipoprotein Cholesterol and Risk of Cardiovascular Events Among Patients Receiving Statin Therapy in the TNT Trial
Antonio J. Vallejo-Vaz et al.
CIRCULATION (2018)
Atherogenic postprandial remnant lipoproteins; VLDL remnants as a causal factor in atherosclerosis
Katsuyuki Nakajima et al.
CLINICA CHIMICA ACTA (2018)
Quantifying Atherogenic Lipoproteins: Current and Future Challenges in the Era of Personalized Medicine and Very Low Concentrations of LDL Cholesterol. A Consensus Statement from EAS and EFLM
Michel R. Langlois et al.
CLINICAL CHEMISTRY (2018)
Regulation of intestinal lipid and lipoprotein metabolism by the proglucagon-derived peptides glucagon like peptide 1 and glucagon like peptide 2
Erin E. Mulvihill
CURRENT OPINION IN LIPIDOLOGY (2018)
Alternative macrophages in atherosclerosis: not always protective!
Benoit Pourcet et al.
JOURNAL OF CLINICAL INVESTIGATION (2018)
Recent Advances in Triacylglycerol Mobilization by the Gut
Changting Xiao et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2018)
Rationale and design of the Pemafibrate to Reduce Cardiovascular Outcomes by Reducing Triglycerides in Patients with Diabetes (PROMINENT) study
Aruna D. Pradhan et al.
AMERICAN HEART JOURNAL (2018)
Large-scale plasma lipidomic profiling identifies lipids that predict cardiovascular events in secondary prevention
Piyushkumar A. Mundra et al.
JCI INSIGHT (2018)
Effects of PCSK9 Inhibition With Alirocumab on Lipoprotein Metabolism in Healthy Humans
Gissette Reyes-Soffer et al.
CIRCULATION (2017)
Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel
Brian A. Ference et al.
EUROPEAN HEART JOURNAL (2017)
Association of Rare and Common Variation in the Lipoprotein Lipase Gene With Coronary Artery Disease
Amit V. Khera et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2017)
Weekday variation in triglyceride concentrations in 1.8 million blood samples
Jorn Jaskolowski et al.
JOURNAL OF LIPID RESEARCH (2017)
ANGPTL3 Deficiency and Protection Against Coronary Artery Disease
Nathan O. Stitziel et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2017)
Omega-3 fatty acids eicosapentaenoic acid and docosahexaenoic acid and their mechanisms of action on apolipoprotein B-containing lipoproteins in humans: a review
Jan Oscarsson et al.
LIPIDS IN HEALTH AND DISEASE (2017)
Evacetrapib and Cardiovascular Outcomes in High-Risk Vascular Disease
A. Michael Lincoff et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Genetic and Pharmacologic Inactivation of ANGPTL3 and Cardiovascular Disease
F. E. Dewey et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Effects of Anacetrapib in Patients with Atherosclerotic Vascular Disease
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Pathophysiological relevance of macrophage subsets in atherogenesis
Luca Liberale et al.
THROMBOSIS AND HAEMOSTASIS (2017)
Dietary Fats and Cardiovascular Disease A Presidential Advisory From the American Heart Association
Frank M. Sacks et al.
CIRCULATION (2017)
Dysfunctional HDL and atherosclerotic cardiovascular disease
Robert S. Rosenson et al.
NATURE REVIEWS CARDIOLOGY (2016)
Triglyceride-Rich Lipoproteins and Atherosclerotic Cardiovascular Disease New Insights From Epidemiology, Genetics, and Biology
Borge G. Nordestgaard
CIRCULATION RESEARCH (2016)
Increased Remnant Cholesterol Explains Part of Residual Risk of All-Cause Mortality in 5414 Patients with Ischemic Heart Disease
Anne-Marie K. Jepsen et al.
CLINICAL CHEMISTRY (2016)
Central nervous system regulation of intestinal lipid and lipoprotein metabolism
Sarah Farr et al.
CURRENT OPINION IN LIPIDOLOGY (2016)
The central role of arterial retention of cholesterol-rich apolipoprotein-B-containing lipoproteins in the pathogenesis of atherosclerosis: a triumph of simplicity
Jan Boren et al.
CURRENT OPINION IN LIPIDOLOGY (2016)
Fasting is not routinely required for determination of a lipid profile: clinical and laboratory implications including flagging at desirable concentration cut-points-a joint consensus statement from the European Atherosclerosis Society and European Federation of Clinical Chemistry and Laboratory Medicine
Borge G. Nordestgaard et al.
EUROPEAN HEART JOURNAL (2016)
Plasma ceramides predict cardiovascular death in patients with stable coronary artery disease and acute coronary syndromes beyond LDL-cholesterol
Reijo Laaksonen et al.
EUROPEAN HEART JOURNAL (2016)
2016 ESC/EAS Guidelines for the Management of Dyslipidaemias
Alberico L. Catapano et al.
EUROPEAN HEART JOURNAL (2016)
VLDL Triglyceride Kinetics in Lean, Overweight, and Obese Men and Women
Bettina Mittendorfer et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2016)
ApoC-III inhibits clearance of triglyceride-rich lipoproteins through LDL family receptors
Philip L. S. M. Gordts et al.
JOURNAL OF CLINICAL INVESTIGATION (2016)
Effects of angiopoietin-like protein 3 deficiency on postprandial lipid and lipoprotein metabolism
Ilenia Minicocci et al.
JOURNAL OF LIPID RESEARCH (2016)
Coding Variation in ANGPTL4, LPL, and SVEP1 and the Risk of Coronary Disease
Nathan O. Stitziel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Inactivating Variants in ANGPTL4 and Risk of Coronary Artery Disease
Frederick F. Dewey et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Remnant Lipoprotein Cholesterol and Incident Coronary Heart Disease: The Jackson Heart and Framingham Offspring Cohort Studies
Parag H. Joshi et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2016)
Nonfasting Mild-to-Moderate Hypertriglyceridemia and Risk of Acute Pancreatitis
Simon B. Pedersen et al.
JAMA INTERNAL MEDICINE (2016)
Triglyceride-Rich Lipoproteins and Remnants: Targets for Therapy?
Geesje M. Dallinga-Thie et al.
CURRENT CARDIOLOGY REPORTS (2016)
New Insights into the Regulation of Chylomicron Production
Satya Dash et al.
ANNUAL REVIEW OF NUTRITION, VOL 35 (2015)
Extreme Nonfasting Remnant Cholesterol vs Extreme LDL Cholesterol as Contributors to Cardiovascular Disease and All-Cause Mortality in 90000 Individuals from the General Population
Anette Varbo et al.
CLINICAL CHEMISTRY (2015)
Anacetrapib lowers LDL by increasing ApoB clearance in mildly hypercholesterolemic subjects
John S. Millar et al.
JOURNAL OF CLINICAL INVESTIGATION (2015)
Cholesterol Crystals Associate With Coronary Plaque Vulnerability In Vivo
Yu Kataoka et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2015)
Fasting Triglycerides Predict Recurrent Ischemic Events in Patients With Acute Coronary Syndrome Treated With Statins
Gregory G. Schwartz et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2015)
Transcriptional regulation of hepatic lipogenesis
Yuhui Wang et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2015)
Antisense Inhibition of Apolipoprotein C-III in Patients with Hypertriglyceridemia
Daniel Gaudet et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Homozygous familial hypercholesterolaemia: new insights and guidance for clinicians to improve detection and clinical management. A position paper from the Consensus Panel on Familial Hypercholesterolaemia of the European Atherosclerosis Society
Marina Cuchel et al.
TURK KARDIYOLOJI DERNEGI ARSIVI-ARCHIVES OF THE TURKISH SOCIETY OF CARDIOLOGY (2015)
Exome sequencing identifies rare LDLR and APOA5 alleles conferring risk for myocardial infarction
Ron Do et al.
NATURE (2015)
Postprandial hypertriglyceridemia as a coronary risk factor
Jan Boren et al.
CLINICA CHIMICA ACTA (2014)
Triglycerides and cardiovascular disease
Borge G. Nordestgaard et al.
LANCET (2014)
Loss-of-Function Mutations in APOC3 and Risk of Ischemic Vascular Disease
Anders Berg Jorgensen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Targeting APOC3 in the Familial Chylomicronemia Syndrome
Daniel Gaudet et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
The polygenic nature of hypertriglyceridaemia: implications for definition, diagnosis, and management
Robert A. Hegele et al.
LANCET DIABETES & ENDOCRINOLOGY (2014)
Homozygous familial hypercholesterolaemia: new insights and guidance for clinicians to improve detection and clinical management. A position paper from the Consensus Panel on Familial Hypercholesterolaemia of the European Atherosclerosis Society
Marina Cuchel et al.
EUROPEAN HEART JOURNAL (2014)
Hepatic Remnant Lipoprotein Clearance by Heparan Sulfate Proteoglycans and Low-Density Lipoprotein Receptors Depend on Dietary Conditions in Mice
Erin M. Foley et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2013)
Dyslipidemia, but not hyperglycemia and insulin resistance, is associated with marked alterations in the HDL lipidome in type 2 diabetic subjects in the DIWA cohort: Impact on small HDL particles
Marcus Stahlman et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2013)
Elevated Remnant Cholesterol Causes Both Low-Grade Inflammation and Ischemic Heart Disease, Whereas Elevated Low-Density Lipoprotein Cholesterol Causes Ischemic Heart Disease Without Inflammation
Anette Varbo et al.
CIRCULATION (2013)
Lipolysis of triglyceride-rich lipoproteins, vascular inflammation, and atherosclerosis
Eric A. Schwartz et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2012)
Postprandial metabolism of meal triglyceride in humans
Jennifer E. Lambert et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2012)
Fish oil - How does it reduce plasma triglycerides?
Gregory C. Shearer et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2012)
The characteristics of remnant lipoproteins in the fasting and postprandial plasma
Katsuyuki Nakajima et al.
CLINICA CHIMICA ACTA (2012)
Hepatic ABC transporters and triglyceride metabolism
John S. Parks et al.
CURRENT OPINION IN LIPIDOLOGY (2012)
The interaction of familial and secondary causes of hypertriglyceridemia: Role in pancreatitis (Reprinted from Association of American Physicians, vol 86, pg 245-253, 1973)
John D. Brunzell et al.
JOURNAL OF CLINICAL LIPIDOLOGY (2012)
Changes in lipoprotein subfraction concentration and composition in healthy individuals treated with the CETP inhibitor anacetrapib
Ronald M. Krauss et al.
JOURNAL OF LIPID RESEARCH (2012)
Dual Metabolic Defects Are Required to Produce Hypertriglyceridemia in Obese Subjects
Marja-Riitta Taskinen et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2011)
Apolipoprotein CIII 42 Years Old and Even More Interesting
Henry N. Ginsberg et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2011)
Triglycerides and Cardiovascular Disease A Scientific Statement From the American Heart Association
Michael Miller et al.
CIRCULATION (2011)
ESC/EAS GUIDELINES ESC/EAS Guidelines for the management of dyslipidaemias
Zeljko Reiner et al.
TURK KARDIYOLOJI DERNEGI ARSIVI-ARCHIVES OF THE TURKISH SOCIETY OF CARDIOLOGY (2011)
Triglyceride-rich lipoproteins and high-density lipoprotein cholesterol in patients at high risk of cardiovascular disease: evidence and guidance for management
M. John Chapman et al.
EUROPEAN HEART JOURNAL (2011)
ESC/EAS Guidelines for the management of dyslipidaemias
Zeljko Reiner et al.
EUROPEAN HEART JOURNAL (2011)
Proteomics of Apolipoproteins and Associated Proteins From Plasma High-Density Lipoproteins
Pia Davidsson et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2010)
Cholesteryl ester transfer protein: at the heart of the action of lipid-modulating therapy with statins, fibrates, niacin, and cholesteryl ester transfer protein inhibitors
M. John Chapman et al.
EUROPEAN HEART JOURNAL (2010)
Lipoprotein(a) as a cardiovascular risk factor: current status
Borge G. Nordestgaard et al.
EUROPEAN HEART JOURNAL (2010)
NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals
Peter Duewell et al.
NATURE (2010)
The ACCORD Study Group. Effects of combination lipid therapy in type 2 diabetes mellitus.
Lukasz Januszkiewicz
KARDIOLOGIA POLSKA (2010)
Cholesterol Crystals Activate the NLRP3 Inflammasome in Human Macrophages: A Novel Link between Cholesterol Metabolism and Inflammation
Kristiina Rajamaki et al.
PLOS ONE (2010)
Effects of Combination Lipid Therapy in Type 2 Diabetes Mellitus
Henry N. Ginsberg et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Brief oral stimulation, but especially oral fat exposure, elevates serum triglycerides in humans
Richard D. Mattes
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2009)
Oro-sensory perception of dietary lipids: New insights into the fat taste transduction
Naim Akhtar Khan et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2009)
Inflammation associated with the postprandial lipolysis of triglyceriderich lipoproteins by lipoprotein lipase
Laura J. Higgins et al.
CURRENT ATHEROSCLEROSIS REPORTS (2009)
Effects of Fenofibrate Treatment on Cardiovascular Disease Risk in 9,795 Individuals With Type 2 Diabetes and Various Components of the Metabolic Syndrome The Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study
Russell Scott et al.
DIABETES CARE (2009)
Major Lipids, Apolipoproteins, and Risk of Vascular Disease
The Emerging Risk Factors Collaboration*
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2009)
Lipid profiling of FPLC-separated lipoprotein fractions by electrospray ionization tandem mass spectrometry
Philipp Wiesner et al.
JOURNAL OF LIPID RESEARCH (2009)
Triglyceride-rich lipoprotein lipolysis releases neutral and oxidized FFAs that induce endothelial cell inflammation
Limin Wang et al.
JOURNAL OF LIPID RESEARCH (2009)
Overproduction of very low-density lipoproteins is the hallmark of the dyslipidemia in the metabolic syndrome
Martin Adiels et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2008)
Fasting and Nonfasting Lipid Levels Influence of Normal Food Intake on Lipids, Lipoproteins, Apolipoproteins, and Cardiovascular Risk Prediction
Anne Langsted et al.
CIRCULATION (2008)
Why Is HDL Functionally Deficient in Type 2 Diabetes?
Anatol Kontush et al.
CURRENT DIABETES REPORTS (2008)
Nonfasting Triglycerides and Risk of Ischemic Stroke in the General Population
Jacob J. Freiberg et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2008)
Impact of triglyceride levels beyond low-density lipoprotein cholesterol after acute coronary syndrome in the PROVE IT-TIMI 22 trial
Michael Miller et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2008)
A Null Mutation in Human APOC3 Confers a Favorable Plasma Lipid Profile and Apparent Cardioprotection
Toni I. Pollin et al.
SCIENCE (2008)
Fasting compared with nonfasting triglycerides and risk of cardiovascular events in women
Sandeep Bansal et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2007)
Triglyceride-rich lipoproteins prime aortic endothelium for an enhanced inflammatory response to tumor necrosis factor-α
Harold J. Ting et al.
CIRCULATION RESEARCH (2007)
Lipoprotein lipase S447X - A naturally occurring gain-of-function mutation
Jaap Rip et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2006)
New insights into the regulation of HDL metabolism and reverse cholesterol transport
GF Lewis et al.
CIRCULATION RESEARCH (2005)
Effects of the PPARγ agonist pioglitazone on lipoprotein metabolism in patients with type 2 diabetes mellitus
K Nagashima et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
Elevated remnant-like particle cholesterol concentration - A characteristic feature of the atherogenic lipoprotein phenotype
TB Twicker et al.
CIRCULATION (2004)
Arterial permeability and efflux of apolipoprotein B-containing lipoproteins assessed by in situ perfusion and three-dimensional quantitative confocal microscopy
SD Proctor et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2004)
Identification of lipoproteins of intestinal origin in human atherosclerotic plaque
S Pal et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2003)
ApoC-III content of apoB-containing lipoproteins is associated with binding to the vascular proteoglycan biglycan
K Olin-Lewis et al.
JOURNAL OF LIPID RESEARCH (2002)
Subendothelial retention of atherogenic lipoproteins in early atherosclerosis
K Skålén et al.
NATURE (2002)
PPARs, metabolic disease and atherosclerosis
JC Fruchart et al.
PHARMACOLOGICAL RESEARCH (2001)
Diurnal triglyceride profiles: a novel approach to study triglyceride changes
MC Cabezas et al.
ATHEROSCLEROSIS (2001)
Remnant lipoproteins as therapeutic targets
RJ Havel
CURRENT OPINION IN LIPIDOLOGY (2000)
Remnant lipoproteins induce proatherothrombogenic molecules in endothelial cells through a redox-sensitive mechanism
H Doi et al.
CIRCULATION (2000)
Action of atorvastatin in combined hyperlipidemia - Preferential reduction of cholesteryl ester transfer from HDL to VLDL1 particles
M Guerin et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2000)
Share Paper
